对PCE,中国-PAR和PREVENT模型的验证和重新校准,用于估计中国的ASCVD风险

Haibin Li1, Shuohua Chen2, Ruolin Zhang3

  • 1Department of Cardiology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China; Medical Research Center, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.

JACC. Asia
|February 20, 2026
PubMed
概括

像PCE和中国-PAR这样的心血管风险模型高估了风险,而PREVENT在中国低估了风险. 重新校准这些动脉样硬化心血管疾病 (ASCVD) 风险得分可以提高初级预防策略的准确性.